
|Videos|May 6, 2021
Looking at real-world trial data replication outcomes of AAO IRIS Registry data
Author(s)David Hutton, OTE Staff Reports
Dr Theodore Leng discusses the highlights from his presentation on "AAO IRIS Registry Data Replicates VIEW 1 and VIEW 2 Clinical Trial Outcome Data," during the virtual 2021 ARVO meeting.
Advertisement
Dr Theodore Leng medical advisor at Verana Health and director of clinical translational research, Byers Eye Institute, Stanford University School of Medicine, discusses the highlights from his presentation on "AAO IRIS Registry Data Replicates VIEW 1 and VIEW 2 Clinical Trial Outcome Data," in which the first replications using real-world data of a phase 3 trial was utilized, during the virtual 2021 ARVO meeting.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
ESCRS 2026: Q&A: What early real-world data reveal about the TECNIS Odyssey
2
The importance of treating EBMD before cataract surgery
3
Laru-zova meets primary endpoint in pivotal VISTA trial for X-linked retinitis pigmentosa
4
"Time is vision": EURETINA President Nicole Eter, MD, previews the 2026 congress
5









